exendin-4 tirzepatide Exendin-4: From lizard to laboratory...and beyond History of glucagon-like peptide-1 receptor

Zhu Y, Mordaunt CE, Yasui DH, et al

Edema and swelling gets better for most patients

Ozempic PILLS could be rolled out within MONTHS See more Daily Mail on Google - save us as a Preferred Source Pharmaceutical giant Eli Lilly announced its obesity-busting drug could offer even greater weight loss benefits than Ozempic and Wegovy

Given this close relationship, scientists have hoped that semaglutide and similar drugs that mimic the hormone GLP-1 (already approved to treat obesity and diabetes) could be an effective treatment for MASLD/MASH as well

By engaging both GIP and GLP-1 receptors, tirzepatide produces a more comprehensive metabolic effect

Here are some key differences to consider: They work in slightly different ways